BIO-RAD LABORATORIES, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Bio Rad Laboratories, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2010 to Q3 2024.
  • Bio Rad Laboratories, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 27.9M shares, a 3.96% decline year-over-year.
  • Bio Rad Laboratories, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 29.2M shares, a 1.93% decline from 2022.
  • Bio Rad Laboratories, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 29.8M shares, a 0.15% decline from 2021.
  • Bio Rad Laboratories, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 29.8M shares, a 0.21% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 27.9M -1.15M -3.96% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-31
Q2 2024 28.4M -960K -3.27% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-02
Q1 2024 28.5M -1.08M -3.64% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 29.2M -576K -1.93% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-16
Q3 2023 29.1M -631K -2.12% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 29.4M -439K -1.47% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-02
Q1 2023 29.6M -337K -1.13% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 29.8M -46K -0.15% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-16
Q3 2022 29.7M -81K -0.27% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-27
Q2 2022 29.8M +30K +0.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 29.9M +110K +0.37% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 29.8M +63K +0.21% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-16
Q3 2021 29.8M +93K +0.31% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-28
Q2 2021 29.8M +112K +0.38% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-29
Q1 2021 29.8M -42K -0.14% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-29
Q4 2020 29.8M -75K -0.25% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-17
Q3 2020 29.7M -110K -0.37% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-29
Q2 2020 29.7M -162K -0.54% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 29.9M +64K +0.22% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q4 2019 29.8M +7K +0.02% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-11
Q3 2019 29.8M -32K -0.11% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-30
Q2 2019 29.8M 0 0% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 29.8M +14K +0.05% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 29.8M +181K +0.61% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-16
Q3 2018 29.9M +203K +0.68% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-01
Q2 2018 29.8M +201K +0.68% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 29.8M +207K +0.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 29.7M +215K +0.73% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 29.7M +216K +0.73% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-05
Q2 2017 29.6M +215K +0.73% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 29.6M +216K +0.74% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 29.4M +254K +0.87% Oct 1, 2016 Dec 31, 2016 10-K 2019-04-01
Q3 2016 29.4M +249K +0.85% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 29.4M +262K +0.9% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 29.4M +272K +0.94% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 29.2M +310K +1.07% Oct 1, 2015 Dec 31, 2015 10-K 2018-04-16
Q3 2015 29.2M +311K +1.08% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-02
Q2 2015 29.1M +310K +1.08% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 29.1M +301K +1.05% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 28.9M +290K +1.01% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-01
Q3 2014 28.9M +281K +0.98% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 28.8M +288K +1.01% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 28.8M +297K +1.04% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q4 2013 28.6M +296K +1.05% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 28.6M +291K +1.03% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 28.5M +288K +1.02% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-06
Q1 2013 28.5M +293K +1.04% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 28.3M +259K +0.92% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-02
Q3 2012 28.3M +240K +0.86% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 28.3M +236K +0.84% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 28.2M +297K +1.06% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 28M +366K +1.32% Oct 1, 2011 Dec 31, 2011 10-K 2014-03-18
Q3 2011 28.1M +375K +1.35% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 28M +408K +1.48% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 27.9M +359K +1.3% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
Q4 2010 27.7M Oct 1, 2010 Dec 31, 2010 10-K 2013-03-18
Q3 2010 27.7M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-03
Q2 2010 27.6M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-04
Q1 2010 27.5M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.